CYP
Click for more information
8.47% 27.0¢ cynata therapeutics limited

Ann: Cynata Investor Presentation, page-58

  1. IndexInvestor
    8,380 Posts.
    lightbulb Created with Sketch. 1381
    clock Created with Sketch.
    17/08/20
    14:43
    Post #: 46595057
    The fact that MSB doesn't own Lonza isn't the problem. The problem is the number of donors which MSB (and Lonza) need.

    Cymerus needs only one donor. Quality is perfectly uniform.
    CYP Price at posting: 70.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
27.0¢ 		Change
-0.025(8.47%) 		Mkt cap ! $48.50M
Open High Low Value Volume
29.5¢ 29.5¢ 27.0¢ $3.553K 12.06K

Buyers (Bids)

No. Vol. Price($)
2 44862 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 2500 1
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.